3Davidson MB. Early insulin therapy for type 2 diabetic patients: more cost than benefit[J]. Diabetes Care, 2005, 28(1): 222-224.
4Moghissi E, King AB. Individualizing insulin therapy in the manage- ment of type 2 diabetes[J]. Am J Med, 2014, 127(10 Suppl): $3-10.
5Duarte DA, Silva KC, Rosales MA, et al. The concomitance of hyper- tension and diabetes exacerbating retinopathy: the role of inflamma- tion and oxidative stress[J]. Curr Clin Pharmacol, 2013, 8(4): 266-277.
6Fiorentino TV, Prioletta A, Zuo P, et al. Hyperglycemia-induced ox- idative stress and its role in diabetes mellitus related cardiovascular diseases[J]. Curt Pharm Des, 2013, 19(32): 5695-5703.
7Vallon V, Komers 1L Pathophysiology of the diabetic kidney [J]. Compr Physiol, 2011, 1(3): 1175-1232.
8Arora MK, Singh UK. Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy[J]. Curr Drug Targets, 2014, 15 (5): 531-538.
9Pitocco D, Tesauro M, Alessandro R, et al. Oxidative stress in dia- betes: implications for vascular and other complications[J]. Int J Mol Sci, 2013, 14(11): 21525-21550.
10Bajaj S, Khan A. Antioxidants and diabetes [J]. Indian J Endoerinol Metab, 2012, 16(Suppl 2): $267-$271.